182 related articles for article (PubMed ID: 32873911)
1. Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes.
Pham TCP; Bojsen-Møller KN; Madsbad S; Wojtaszewski JFP; Richter EA; Sylow L
Int J Obes (Lond); 2021 Feb; 45(2):316-325. PubMed ID: 32873911
[TBL] [Abstract][Full Text] [Related]
2. Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes.
Sylow L; Vind BF; Kruse R; Møller PM; Wojtaszewski JFP; Richter EA; Højlund K
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112102
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle.
Han X; Møller LLV; De Groote E; Bojsen-Møller KN; Davey J; Henríquez-Olguin C; Li Z; Knudsen JR; Jensen TE; Madsbad S; Gregorevic P; Richter EA; Sylow L
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1241-1257. PubMed ID: 31402604
[TBL] [Abstract][Full Text] [Related]
4. Follistatin secretion is enhanced by protein, but not glucose or fat ingestion, in obese persons independently of previous gastric bypass surgery.
Bojsen-Møller KN; Svane MS; Jensen CZ; Kjeldsen SAS; Holst JJ; Wewer Albrechtsen NJ; Madsbad S
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G753-G758. PubMed ID: 33655762
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
6. Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes.
Almby KE; Katsogiannos P; Pereira MJ; Karlsson FA; Sundbom M; Wiklund U; Kamble PG; Eriksson JW
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4049-e4061. PubMed ID: 34086911
[TBL] [Abstract][Full Text] [Related]
7. Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.
Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Tsilingiris D; Alexandrou A; Mantzoros CS
Diabetes Metab Res Rev; 2020 Jul; 36(5):e3297. PubMed ID: 32026536
[TBL] [Abstract][Full Text] [Related]
8. Changes in Bone Marrow Adipose Tissue One Year After Roux-en-Y Gastric Bypass: A Prospective Cohort Study.
Blom-Høgestøl IK; Mala T; Kristinsson JA; Hauge EM; Brunborg C; Gulseth HL; Eriksen EF
J Bone Miner Res; 2019 Oct; 34(10):1815-1823. PubMed ID: 31216081
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
[TBL] [Abstract][Full Text] [Related]
10. Follistatins in glucose regulation in healthy and obese individuals.
Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Tsilingiris D; Alexandrou A; Mantzoros CS
Diabetes Obes Metab; 2019 Mar; 21(3):683-690. PubMed ID: 30393997
[TBL] [Abstract][Full Text] [Related]
11. Changes in bone quality after Roux-en-Y gastric bypass: A prospective cohort study in subjects with and without type 2 diabetes.
Blom-Høgestøl IK; Mala T; Kristinsson JA; Brunborg C; Gulseth HL; Eriksen EF
Bone; 2020 Jan; 130():115069. PubMed ID: 31593823
[TBL] [Abstract][Full Text] [Related]
12. Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D.
Katsogiannos P; Kamble PG; Boersma GJ; Karlsson FA; Lundkvist P; Sundbom M; Pereira MJ; Eriksson JW
J Clin Endocrinol Metab; 2019 Jul; 104(7):2601-2613. PubMed ID: 30689903
[TBL] [Abstract][Full Text] [Related]
13. Carotid intima-media thickness is reduced 12 months after gastric bypass surgery in obese patients with type 2 diabetes or impaired glucose tolerance.
Lundby-Christensen L; Tarnow L; Hansen DL; Worm D; Naver LS; Hvolris LE; Wiinberg N; Vaag A; Almdal TP
J Diabetes Complications; 2014; 28(4):517-22. PubMed ID: 24685364
[TBL] [Abstract][Full Text] [Related]
14. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
[TBL] [Abstract][Full Text] [Related]
15. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
16. Decreased visceral fat area correlates with improved total testosterone levels after Roux-en-Y gastric bypass in obese Chinese males with type 2 diabetes: a 12-month follow-up.
Liu F; Tu Y; Zhang P; Bao Y; Han J; Jia W
Surg Obes Relat Dis; 2018 Apr; 14(4):462-468. PubMed ID: 29254689
[TBL] [Abstract][Full Text] [Related]
17. Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes.
Jørgensen NB; Bojsen-Møller KN; Dirksen C; Martinussen C; Svane MS; Kristiansen VB; Holst JJ; Madsbad S
Sci Rep; 2019 Oct; 9(1):15154. PubMed ID: 31641146
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of bariatric surgery on patients with type 2 diabetes: a population-based study.
Akpinar EO; Liem RSL; Nienhuijs SW; Greve JWM; Marang-van de Mheen PJ;
Surg Obes Relat Dis; 2021 Jul; 17(7):1349-1358. PubMed ID: 33762128
[TBL] [Abstract][Full Text] [Related]
19. Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.
Thomsen SB; Rathcke CN; Jørgensen NB; Madsbad S; Vestergaard H
J Obes; 2013; 2013():361781. PubMed ID: 24303210
[TBL] [Abstract][Full Text] [Related]
20. Spatial expression patterns of activin and its signaling system in the zebrafish ovarian follicle: evidence for paracrine action of activin on the oocytes.
Wang Y; Ge W
Biol Reprod; 2003 Dec; 69(6):1998-2006. PubMed ID: 12930712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
